Product description

Palexia SR 100mg tapentadol (as hydrochloride) sustained release tablets
Blister strips
Batches 985P01 and 986P01
Expiry Date 31/01/2022

This recall has been expanded to include Batch 986P01 from 20 March 2020.

AUST R 165346

Palexia SR is used in the management of moderate to severe chronic pain in patients who meet certain criteria.

See a list of details to help identify the product.

Reason the product is recalled

Blister strips may have faded or missing labelling relating to the batch number or expiry details. The recall is only because of a labelling issue. The quality of the product is not affected.

The hazards to consumers

The absence of product and batch/expiry details on the blister strips compromises the identity of the product and could present a risk of product mix-up and overdose, especially when the same patient is using more than one strength of medicine on any given day.

What consumers should do

If you, or a person your provide care for, uses Palexia SR 100mg tablets, please check the batch number printed on the cardboard outer box (on the end of the carton). If you have a pack from either batch 985P01 or 986P01, check the individual blister strips to ensure the product details are fully legible.

If the blister strips are affected by this printing issue, return those strips to the pharmacy where you purchased them for a suitable replacement or refund.

For further information, call Seqirus Customer Service on 1800 008 275.

Details to help identify the product.

Supplier running the recall

Who sold the product

Pharmacies and Chemists

Identifying numbers

Other identifying numbers

Batch 985P01 and 986P01

Dates available for sale

-

Where the product was sold

Nationally

Responsible regulators

Regulators are established or appointed by government. They enforce regulations and rules.

Quote PRA number 2020/18188 when contacting a regulator about this recall.

Recall and remedy questions

Contact the Therapeutic Goods Administration if you have:

  • a question about the remedy being offered to you by the business that is responsible for managing this recall, or
  • concerns about the way the business is managing this recall.